Anti-BRG1 antibody [EPR3912]
- Recombinant
- KO Validated
- Advanced Validation
- RabMAb
- What is this?
5
(2 Reviews)
|
(8 Publications)
Anti-BRG1 antibody [EPR3912] (ab108318) is a rabbit monoclonal antibody detecting BRG1 in Western Blot, Flow Cytometry (Intra), IP, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
View Alternative Names
BAF190A, BRG1, SNF2B, SNF2L4, SMARCA4, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4, BRG1-associated factor 190A, Mitotic growth and transcription activator, Protein BRG-1, Protein brahma homolog 1, SNF2-beta, Transcription activator BRG1
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BRG1 antibody [EPR3912] (AB108318)
Immunohistochemical analysis of formalin fixed paraffin embedded human tonsil labelling BRG1 with ab108318 at a concentration of 4 µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.
ab108318 Anti-BRG1 antibody [EPR3912] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual)
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-BRG1 antibody [EPR3912] (AB108318)
ab108318 (unpurified) staining BRG1 in wild-type HAP1 cells (top panel) and BRG1 knockout HAP1 cells (bottom panel). The cells were fixed with 4% formaldehyde (10min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab108318 at 1/500 dilution and ab195889 at 1/250 dilution (shown in pseudocolour red) overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to Rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-BRG1 antibody [EPR3912] (AB108318)
Intracellular Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling BRG1 with purified ab108318 at 1/20 dilution (10μg/ml) (red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluorr® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-BRG1 antibody [EPR3912] (AB108318)
Immunocytochemistry/ Immunofluorescence analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling BRG1 with purified ab108318 at 1/50 dilution (2.3 μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1/200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-BRG1 antibody [EPR3912] (AB108318)
ab108318 (unpurified) staining BRG1 in HeLa cells. The cells were fixed with 4% formaldehyde (10min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab108318 at 1/500 dilution and ab195889 at 1/250 dilution (shown in pseudocolour red) overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to Rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BRG1 antibody [EPR3912] (AB108318)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human bladder cancer tissue sections labeling BRG1 with purified ab108318 at 1/500 dilution (0.23 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- IP
Lab
Immunoprecipitation - Anti-BRG1 antibody [EPR3912] (AB108318)
BRG1 was immunoprecipitated from K-562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate with ab108318 at 1/30 dilution (2µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab108318 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used as secondary antibody at 1/5000 dilution. Lane 1 (Input) : K-562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate, 10 μg Lane 2 (+) : K-562 whole cell lysate Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab108318 in K-562 whole cell lysate Blocking and diluting buffer and concentration : 5% NFDM/TBST. Observed MW : 185 kDa.
All lanes:
Immunoprecipitation - Anti-BRG1 antibody [EPR3912] (ab108318) at 1/1000 dilution
Lane 1:
K-562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate at 10 µg
Lane 2:
K-562 whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Predicted band size: 185 kDa
Observed band size: 185 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BRG1 antibody [EPR3912] (AB108318)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Mouse stomach tissue sections labeling BRG1 with purified ab108318 at 1/500 dilution (0.23 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BRG1 antibody [EPR3912] (AB108318)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Rat stomach tissue sections labeling BRG1 with purified ab108318 at 1/500 dilution (0.23 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- IP
Lab
Immunoprecipitation - Anti-BRG1 antibody [EPR3912] (AB108318)
BRG1 was immunoprecipitated from NIH/3T3 (mouse embryonic fibroblast), whole cell lysate with ab108318 at 1/30 dilution (2µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab108318 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used as secondary antibody at 1/5000 dilution. Lane 1 (Input) : NIH/3T3 (mouse embryonic fibroblast), whole cell lysate, 10 μg Lane 2 (+) : NIH/3T3 whole cell lysate Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab108318 in NIH/3T3 whole cell lysate Blocking and diluting buffer and concentration : 5% NFDM/TBST. Observed MW : 185 kDa.
All lanes:
Immunoprecipitation - Anti-BRG1 antibody [EPR3912] (ab108318) at 1/1000 dilution
Lane 1:
NIH/3T3 (mouse embryonic fibroblast), whole cell lysate at 10 µg
Lane 2:
NIH/3T3 whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Predicted band size: 185 kDa
Observed band size: 185 kDa
false
- WB
Lab
Western blot - Anti-BRG1 antibody [EPR3912] (AB108318)
All lanes:
Western blot - Anti-BRG1 antibody [EPR3912] (ab108318) at 1/1000 dilution
Lane 1:
K-562 (Human chronic myelogenous leukemia lymphoblast) whole cell lysates at 20 µg
Lane 2:
NIH/3T3 (Mouse embryonic fibroblast) whole cell lysates at 20 µg
Lane 3:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 185 kDa
Observed band size: 185 kDa
false
- WB
Lab
Western blot - Anti-BRG1 antibody [EPR3912] (AB108318)
Lanes 1 - 4 : Merged signal (red and green). Red - loading control, ab18058 (unpurified), observed at 124 kDa.
ab108318 was shown to specifically react with BRG1 in wild-type HAP1 cells along with additional cross reactive bands. No band was observed when BRG1 knockout samples were used. Wild-type and BRG1 knockout samples were subjected to SDS-PAGE, ab108318 and ab18058 (loading control to Vinculin) were diluted 1/1000 and 1/10,000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10,000 dilution for 1hr at room temperature before imaging.
All lanes:
Western blot - Anti-BRG1 antibody [EPR3912] (ab108318) at 1/1000 dilution
Lane 1:
Wild-type HAP1 cell lysate at 20 µg
Lane 2:
BRG1 knockout HAP1 cell lysate at 20 µg
Lane 3:
K562 cell lysate at 20 µg
Lane 4:
Molt-4 cell lysate at 20 µg
Predicted band size: 185 kDa
Observed band size: 185 kDa
false
- WB
Lab
Western blot - Anti-BRG1 antibody [EPR3912] (AB108318)
Different batches of ab108318 were tested on K-562 (Human chronic myelogenous leukemia lymphoblast) lysate at 0.05 µg/ml. 15 µg of lysate was loaded in each lane. Bands observed at 185 kDa.
All lanes:
Western blot - Anti-BRG1 antibody [EPR3912] (ab108318)
Predicted band size: 185 kDa
false
- WB
Lab
Western blot - Anti-BRG1 antibody [EPR3912] (AB108318)
Lanes 1- 2 : Merged signal (red and green). Green - ab108318 observed at 185 kDa. Red - Anti-Vinculin antibody [VIN-54] observed at 124 kDa.
ab108318 was shown to react with SMARCA4 in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab255432 (knockout cell lysate ab263853) was used. Wild-type HEK-293T and SMARCA4 knockout HEK-293T cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab108318 and Anti-Vinculin antibody [VIN-54] overnight at 4°C at a 1 in 10000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-BRG1 antibody [EPR3912] (ab108318) at 1/10000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
SMARCA4 knockout HEK-293T cell lysate at 20 µg
Lane 2:
Western blot - Human SMARCA4 (BRG1) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-smarca4-brg1-knockout-hek-293t-cell-line-ab255432'>ab255432</a>)
Predicted band size: 185 kDa
Observed band size: 185 kDa
false
- ChIC/CUT&RUN-seq
Supplier Data
ChIC/CUT&RUN sequencing - Anti-BRG1 antibody [EPR3912] (AB108318)
ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5 x 10^5 HeLa (Human cervix adenocarcinoma epithelial cell line) cells and 5µg of ab108318 [EPR3912]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- WB
Lab
Western blot - Anti-BRG1 antibody [EPR3912] (AB108318)
All lanes:
Western blot - Anti-BRG1 antibody [EPR3912] (ab108318) at 1/10000 dilution
All lanes:
RAW264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 185 kDa
Observed band size: 185 kDa
false
- WB
Unknown
Western blot - Anti-BRG1 antibody [EPR3912] (AB108318)
All lanes:
Western blot - Anti-BRG1 antibody [EPR3912] (ab108318) at 1/1000 dilution
Lane 1:
K562 cell lysate at 10 µg
Lane 2:
Molt-4 cell lysate at 10 µg
Predicted band size: 185 kDa
false
Related conjugates and formulations (11)
-
Anti-BRG1 antibody [EPR3912] - BSA and Azide free (Capture)
-
Anti-BRG1 antibody [EPR3912] - BSA and Azide free
-
578 PE
PE Anti-BRG1 antibody [EPR3912]
-
660 APC
APC Anti-BRG1 antibody [EPR3912]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-BRG1 antibody [EPR3912]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-BRG1 antibody [EPR3912]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-BRG1 antibody [EPR3912]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-BRG1 antibody [EPR3912]
-
HRP Anti-BRG1 antibody [EPR3912]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-BRG1 antibody [EPR3912]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-BRG1 antibody [EPR3912]
Reactivity data
Product details
Anti-BRG1 antibody [EPR3912] (ab108318) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ChIC/CUT&RUN-seq, Flow Cyt (Intra), ICC/IF, IHC-P, IP, and WB.
Abcam's high quality manufacturing and validation processes ensure Anti-BRG1 antibody [EPR3912] (ab108318) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-BRG1 antibody [EPR3912] (ab108318) has been confirmed by Western Blot testing in BRG1 knockout HEK-293T cells (ab263853).
Anti-BRG1 antibody [EPR3912] (ab108318) specifically detects BRG1 (UniProt ID: P51532; Molecular weight: 185kDa) and is sold in 100 µL and 1 mL selling sizes.
Conjugation-ready, carrier free format available for antibody clone EPR3912 - ab222230.
Antibody clone EPR3912 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647, Alexa Fluor® 488, PE, APC, HRP, Alkaline Phosphatase, Alexa Fluor® 594, Alexa Fluor® 555, Alexa Fluor® 568, Alexa Fluor® 750 (ab206598, ab206712, ab305626, ab305627, ab305628, ab308772, ab310487, ab312016, ab312493, ab320893).
Validated for CUT&RUN-seq, a key application to map protein-DNA interactions on a genome-wide scale using NGS. Highly specific BRG1 antibody, essential for researchers studying the SWI/SNF complex and chromatin remodeling. BRG1 is widely studied in the context of epigenetic regulation, BRG1 mutations, and cancer research. The BRM/BRG1-containing SWI/SNF complexes are recruited by transcription factors like p53 and BRCA1 to regulate gene activation, cell growth, and differentiation. BRM and BRG1 act as tumor suppressors, with their expression significantly reduced in various cancer cell lines.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Cancer cell 41:1516-1534.e9 PubMed37541244
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:5969 PubMed36216795
2022
Applications
Unspecified application
Species
Unspecified reactive species
Histopathology 77:231-239 PubMed32268438
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research 38:502 PubMed31870402
2019
Applications
Unspecified application
Species
Unspecified reactive species
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 32:1675-1687 PubMed31190001
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature chemical biology 15:672-680 PubMed31178587
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 92: PubMed29848589
2018
Applications
Unspecified application
Species
Unspecified reactive species
Cancer research 75:3865-3878 PubMed26139243
2015
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com